CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


This is an archived document. The links are no longer being updated.

TB Notes 2, 2003


American Thoracic Society/CDC/Infectious Diseases Society of America: Treatment of Tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.

CDC. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR 2003; 52(RR-2): 15-18.

CDC. Trends in tuberculosis morbidity-United States, 1992-2002. MMWR 2003; 52: 217-222.

CDC. Transmission of Mycobacterium tuberculosis associated with failed completion of treatment for latent tuberculosis infection—Chickasaw County, Mississippi, June 1999-March 2002. MMWR 2003; 52: 222-224.

Driver CR, Cordova IM, Munsiff SS. Targeting tuberculosis testing: the yield of source case investigations for young children with reactive tuberculin skin tests. Public Health Rep 2002 Jul-Aug; 117(4): 366-72.

Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 2002 Oct 15; 137(8): 640-7.

Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis 2003 Mar 1; 36(5): 599-607.

Lobato MN, Leary L, Simone P. Treatment of latent TB in correctional facilities, a challenge for TB elimination. Am J Prev Med 2003; 24(3): 249-253.

LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int J Tuberc Lung Dis 2003 Feb; 7(2): 180-5.

Narayanan S, Das S, Garg R, Hari L, Rao VB, Frieden TR, Narayanan PR. Molecular epidemiology of tuberculosis in a rural area of high prevalence in south India: implications for disease control and prevention. J Clin Microbiol 2002 Dec; 40(12): 4785-8.

Selvakumar N, Govindan D, Chandu NA, Frieden TR, Narayanan PR. Processing sputum specimens in a refrigerated centrifuge does not increase the rate of isolation of Mycobacterium tuberculosis. J Clin Microbiol 2003 Jan; 41(1): 469-71.

Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ 2003 Mar 15; 326: 574-79.


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333